Daratumumab biosimilar (Hangzhou Jiuyuan Gene Engineering)
达雷妥尤单抗生物类似药（杭州九源基因工程）
Report date: 2025/11/05 10:34:47
Base Information
Drug NameDaratumumab biosimilar (Hangzhou Jiuyuan Gene Engineering)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHangzhou Jiuyuan Gene Biomedical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesHangzhou Jiuyuan Gene Biomedical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A